1. Natural Products
  2. Plants
  3. Polyporaceae
  4. Ganoderma lucidum (Leyss. Ex Fr.) Karst.

Ganoderma lucidum (Leyss. Ex Fr.) Karst.

Ganoderma lucidum (Leyss. Ex Fr.) Karst. (34):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N1447
    Ganoderic acid A 81907-62-2 99.84%
    Ganoderic acid A can inhibit of the JAK-STAT3 signaling pathway, also inhibit proliferation, viability, ROS.
    Ganoderic acid A
  • HY-N1511
    Ganoderic acid D 108340-60-9 99.89%
    Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis.
    Ganoderic acid D
  • HY-120140
    Ganoderic acid DM 173075-45-1 99.87%
    Ganoderic acid DM, a natural triterpenoid isolated from Ganoderma lucidum, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Ganoderic acid DM as a specific inhibitor of osteoclastogenesis.
    Ganoderic acid DM
  • HY-N6036
    Ganoderic acid F 98665-15-7 99.70%
    Ganoderic acid F is a ganoderic acid. Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum stress.
    Ganoderic acid F
  • HY-N1517
    Ganoderic acid C2 103773-62-2 99.72%
    Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses the potential anti-tumor bioactivity, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 is the inhibitor for aldose reductase with an IC50 of 43.8 µM.
    Ganoderic acid C2
  • HY-N17421
    (7β,22E)-7,8-Epoxyergosta-4,22-diene-3,6-dione 2568879-54-7
    (7β,22E)-7,8-Epoxyergosta-4,22-diene-3,6-dione (Compound 1) is a steroidal compound. It can be extracted from Ganoderma lingzhi. (7β,22E)-7,8-Epoxyergosta-4,22-diene-3,6-dione exhibits anticancer activity against non-small cell lung cancer and breast cancer.
    (7β,22E)-7,8-Epoxyergosta-4,22-diene-3,6-dione
  • HY-N13723
    Methyl lucidenate D 98665-09-9
    Methyl lucidenate D is a selective inhibitor of Epstein-Barr virus early antigen (EBV-EA) activation with an IC50 of 290 mol ratio/32 pmol TPA. Methyl lucidenate D exerts potential anti-tumor promoting activity by inhibiting TPA-induced EBV-EA activation and maintains major Raji cell survival (70%) at effective concentrations. Methyl lucidenate D can be used in the field of cancer chemoprevention.
    Methyl lucidenate D
  • HY-N1506
    Ganodermanontriol 106518-63-2
    Ganodermanontriol, a sterol isolated from Ganoderma lucidum, induces anti-inflammatory activity in tert-butyl hydroperoxide (t-BHP)-damaged hepatic cells through the expression of HO-1. Ganodermanontriol exhibits hepatoprotective activity.
    Ganodermanontriol
  • HY-N2006
    Ganoderic acid B 81907-61-1 99.60%
    Ganoderic acid B is a triterpene isolated from a mushroom Ganoderma lucidum. Ganoderic acid B inhibits the activation of Epstein-Barr virus (EBV) antigens as telomerase inhibitor. Ganoderic acid B is a moderately active inhibitor against HIV-1 protease (IC50: 170 μM).
    Ganoderic acid B
  • HY-N2458
    Ganoderic acid G 98665-22-6 99.93%
    Ganoderic acid G is a highly oxidized lanostane-type triterpenoid compound. Ganoderic acid G can be isolated from the fungus Ganoderma lucidum.
    Ganoderic acid G
  • HY-N2999
    Ganoderic acid I 98665-20-4 99.14%
    Ganoderic acid I is a lanostane-type triterpenoid compound present in Ganoderma lucidum.
    Ganoderic acid I
  • HY-107260
    Lucidenic acid D 98665-16-8 99.78%
    Lucidenic acid D is a highly oxidized triterpenoid with anti-inflammatory and antiviral activities. Lucidenic acid D attenuates lipopolysaccharide-induced release of proinflammatory cytokines and nitric oxide, reduces the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and inhibits skin inflammation. Lucidenic acid D suppresses 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced expression of Epstein-Barr virus (EBV) early antigen and maintains the viability of Raji cells. Lucidenic acid D can be used in studies of cancer chemoprevention.
    Lucidenic acid D
  • HY-N2221
    Ganoderal A 104700-98-3
    Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor.
    Ganoderal A
  • HY-N2223
    Ganoderol B 104700-96-1
    Ganoderol B is a potent α-glucosidase inhibitor. Ganoderol B has high α-glucosidase inhibition with an IC50 of 48.5 μg/mL (119.8 μM).
    Ganoderol B
  • HY-N1512
    Ganoderic acid E 98665-14-6 98.08%
    Ganoderic acid E is a triterpenoid found in Ganoderma lucidum.
    Ganoderic acid E
  • HY-129151
    Ganoderic acid C1 95311-97-0
    Ganoderic acid C1, a natural compound that could be isolated from G. lucidum, suppresses TNF-α production by murine macrophages (RAW 264.7 cells).
    Ganoderic acid C1
  • HY-129150
    Ganoderic acid TR 862893-75-2 98.0%
    Ganoderic acid TR is a broad-spectrum inhibitor of influenza neuraminidase enzymes (NAs). Ganoderic acid TR has IC50 values of 10.9 and 4.6 μM for H5N1 and H1N1 NAs, respectively. Ganoderic acid TR is limited by cytotoxicity and shows only weak activity against Oseltamivir (HY-13317)-resistant H1N1 viruses and influenza B viruses.
    Ganoderic acid TR
  • HY-N2996
    Ganodermanondiol 107900-76-5 99.24%
    Ganodermanondiol is a melanogenesis inhibitor isolated from the Ganoderma lucidum.Ganodermanondiol exhibits potent cytoprotective effects on tert-butyl hydroperoxide-induced hepatotoxicity. Ganodermanondiol shows significant anti-HIV-1 protease activity with an IC50 of 90 μM. Ganodermanondiol exhibits a strong anticomplement activity against the classical pathway of the complement system with an IC50 of 41.7μM.
    Ganodermanondiol
  • HY-N1516
    Ganoderenic acid D 100665-43-8 99.51%
    Ganoderenic acid D is a triterpene identified from the effective compounds of Ganoderma lucidum extract (GLE). Ganoderenic acid D inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis.
    Ganoderenic acid D
  • HY-N1515
    Ganoderenic acid C 100665-42-7 99.87%
    Ganoderenic acid C is a triterpenoid isolated from Ganoderma lingzhi. Ganoderenic acid C is abundant in fruit bodies at an early growth stage.
    Ganoderenic acid C